-
Explains how to establish and conduct telehealth consultations and describes the growing number of options in telehealth diagnostics, patient monitoring, and digital therapeutics.
-
Offers practical examples of conducting telehealth visits for common adult and pediatric urological complaints, for both benign and malignant conditions.
-
Guides readers step by step through the many practical challenges of telemedicine for clinicians, patients, and practices, and describes the opportunities that lay ahead for the field.
-
Covers regulatory, compliance, and technical principles of telehealth devices and applications for use in urology, including key topics such as data protection, patient privacy, e-prescribing, remote diagnostics and monitoring, and much more.
Please Note: This is an On Demand product, delivery may take up to 11 working days after payment has been received.
Table of Contents
- Regulations and Requirements for Telehealth Provision
- Patient Privacy Laws
- Getting Started in Telehealth
- Infrastructure and Sercurity in Telehealth
- Patient Considerations and Leading Change for Telehealth Providers
- Telehealth Tools, Conducting a Consultation and the Ethical Practice of Telemedicine
- Remote Diagnostics in Urology
- Remote Patient Monitoring in Urology
- Digital Therapeutics
- Remote Surgery
- E-prescribing�����������������������������������������������������������������������������������������������������������������������������������������������������������
Authors
Dara Lundon Director of Clinical Trials & Innovation, Assistant Professor of Urology, Icahn School of Medicine at Mount Sinai, New York, New York. Dara Lundon - Dr.Lundon MD MBA PhD is Director of Clinical Trials and Innovation at the Icahn School of Medicine at Mount Sinai New York. Dr. Lundon graduated from The School of Medicine at University College Dublin where he was admitted as an Entrance Scholar for outstanding academic achievement. He undertook his residency in Ireland and subsequently completed his Ph.D in Prostate Cancer Biology under the supervision of Professor R.W.G Watson and the late Professor John M. Fitzpatrick. Dr. Lundon received a scholarship to the NCI Cancer Prevention Program at the NIH in Bethesda MD and completed a fellowship in NYU under the supervision of Professor Stacy Loeb. Dr. Lundon completed an MBA and was an analyst on the number 1 ranked team on Wall Street in Large Cap Pharma, Biotech and Specialty Pharma. Prostate biopsy is an invasive procedure with a risk of significant morbidity. Dr. Lundon's clinical research work has translated discoveries from bench to bedside and helped reduce the number of unnecessary prostate biopsies in menAs well as other yet to be confirmed subject matter experts for each volume
